In response to growing Institute for Clinical and Economic Review (ICER) activity, Jenny Lee and Eric Latch take a revised look at payer reliance on ICER assessments and perceptions on value-based pricing.
Jenny Lee and Eric Latch
Advertisement
Jenny Lee, PharmD, MBA, MPH, is Consultant, Global Pricing & Market Access, and Eric Latch, MSis Senior Analyst, Global Pricing & Market Access, both at ICON.
Articles by Jenny Lee and Eric Latch
Advertisement
Latest Updated Articles
Trends in Payer Reliance on ICER AssessmentsPublished: November 13th 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Proven Playbook: Buy, Partner, Scale, Spin-Off, Optimize
2
Bristol Myers Squibb Expands its Strategic Collaboration with Sarah Cannon Research Institute
3
HHS and FDA Appoint Richard Pazdur as Director of The Center for Drug Evaluation and Research
4
AstraZeneca Stock Becomes UK’s Biggest Stock
5
